Bioventus shareholders elect all six director nominees, ratify Grant Thornton as auditor for FY2025

Bioventus Inc.

All six Class I director nominees elected with 58M to 64.9M votes; broker non-votes 8.59M each.
Ratification of Grant Thornton as auditor: 73.46M for, 149k against, 11k abstain.
Turnout: 73.62M shares (89.76% of outstanding) present at June 3, 2025 annual meeting.
Directors elected until 2026 annual meeting: Claypoole, Cowdy, McMurry-Heath, Neels, Nohra, Sutter.
No other business voted on; all proposals passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.